BEDFORD, Mass.--(BUSINESS WIRE)--Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced that it has appointed Philip J. Vickers, Ph.D., to the position of Chief Scientific Officer. In this role, Dr. Vickers will play a critical role in leading Resolvyx’s research and drug discovery activities, and will serve on the company’s management team. Dr. Vickers will also join the Resolvyx board of directors.
